# A Study of Cytisinicline for Smoking Cessation in Adult Smokers

> **NCT04576949** · PHASE3 · COMPLETED · sponsor: **Achieve Life Sciences** · enrollment: 810 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Cytisinicline
- **DRUG:** Placebo
- **BEHAVIORAL:** Behavioral support

## Key facts

- **NCT ID:** NCT04576949
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-13
- **Primary completion:** 2021-12-23
- **Final completion:** 2021-12-23
- **Target enrollment:** 810 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04576949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04576949, "A Study of Cytisinicline for Smoking Cessation in Adult Smokers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04576949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*